Truist reiterates Buy on C.H. Robinson stock after RXO acquisition
Truist reiterated a Buy rating and $215 price target on C.H. Robinson (CHRW) after its $5.8B acquisition of RXO, a 29% premium. The deal, 57% cash and 43% stock, is expected to close in early 2027. CHRW shares fell to $140.61, trading above fair value with a P/E of 26.95. RXO has $7B revenue but 0% margin, while CHRW reported $17B revenue with 8.45% gross margin. Jefferies and Bank of America also commented, with mixed price target adjustments.
How this was made
The 30-second read
Why it matters
The acquisition is the primary catalyst, providing a clear actionable signal for traders.
Market read
A large‑cap logistics M&A with immediate premium to target and analyst upgrades creates a high‑impact trading opportunity.
What to watch
Regulatory approval timeline and financing cost of the cash portion may introduce downside.
Background
Truist and Jefferies reaffirmed Buy ratings on CHRW following the acquisition announcement, while Bank of America lowered its price target.
Ticker impact
Truist reiterated a Buy on C.H. Robinson (CHRW) with a $215 price target after the company announced a $5.8 B cash‑and‑stock acquisition of RXO.
likely upside as the market prices in the strategic expansion and buy rating
Buy rating and price target increase provide a clear near‑term catalyst.
RXO shareholders will receive cash and CHRW shares in the $5.8 B acquisition, making RXO a direct subject of the deal.
upward pressure on RXO shares as the premium is priced in
Deal terms disclose a clear premium, driving short‑term price appreciation.
Market effects
Logistics and transportation sector may see consolidation pressure and higher valuation multiples.
U.S. logistics stocks could benefit from perceived strategic M&A activity.
The deal underscores continued M&A momentum in global freight and supply‑chain services.
Counterpoint
Potential integration risks and dilution could weigh on CHRW if synergies fall short.
Key entities
- CompanyC.H. Robinson Worldwide
Acquirer in the $5.8 B deal.
- CompanyRXO
Target being acquired.

